Supervie Virginie, Viard Jean-Paul, Costagliola Dominique, Breban Romulus
Sorbonne Universités, UPMC Univ Paris 06, UMR_S 1136 Pierre Louis Institute of Epidemiology and Public Health INSERM, UMR_S 1136 Pierre Louis Institute of Epidemiology and Public Health.
Sorbonne Paris Cité, Faculté de Médecine, Université Paris Descartes, EA7327 APHP, Centre de Diagnostic et de Thérapeutique, Hôpital de l'Hôtel-Dieu.
Clin Infect Dis. 2014 Jul 1;59(1):115-22. doi: 10.1093/cid/ciu223. Epub 2014 Apr 9.
Although essential for patient counseling and quality of life of human immunodeficiency virus (HIV)-infected individuals, the risk of HIV transmission during 1 unprotected sex act with an HIV-infected person under combination antiretroviral therapy (cART) remains unknown.
We reviewed systematically the literature for studies on HIV transmission among heterosexual HIV-serodiscordant couples, where the infected partner was on cART, with regular virological monitoring, reporting on condom use and sexual activity. We used Bayesian statistics to combine data from selected studies, to investigate the per-act risk of HIV transmission through unprotected sex with an HIV-infected person on cART for >6 months.
At most, 1 HIV transmission, over an estimated 113 480 sex acts, of which 17% were not condom protected, was reported within 1672 HIV-serodiscordant couples where the index partner had been treated for >6 months. Data were insufficient to determine whether the reported transmission occurred before or after 6 months of cART. We estimated the upper-bound per-act risk of HIV transmission at either 8.7 or 13:100 000, depending on whether the transmission occurred before or after 6 months of cART. These estimates applied whether or not index partners were virally suppressed. Estimating an upper-bound risk <1:100 000 would require observing no HIV transmission while collecting >12 times the available amount of data.
Available data do not support zero risk of HIV transmission under cART. The per-act risk of HIV transmission through unprotected sex with HIV-infected individuals on cART in comprehensive care for >6 months (whether or not virally suppressed) is <13:100 000. Estimating a 10-fold lower upper-bound risk may be unfeasible due to high condom use among HIV-serodiscordant couples in most research studies.
虽然对于人类免疫缺陷病毒(HIV)感染者的患者咨询和生活质量至关重要,但在接受联合抗逆转录病毒疗法(cART)的情况下,与HIV感染者进行1次无保护性行为期间的HIV传播风险仍不明确。
我们系统回顾了关于异性HIV血清学不一致夫妇中HIV传播的研究文献,其中感染伴侣接受cART治疗,并进行定期病毒学监测,报告避孕套使用情况和性活动。我们使用贝叶斯统计方法合并选定研究的数据,以调查与接受cART治疗超过6个月的HIV感染者进行无保护性行为时每次行为的HIV传播风险。
在1672对HIV血清学不一致夫妇中,其中索引伴侣接受治疗超过6个月,据报告在估计的113480次性行为中最多有1次HIV传播,其中17%未使用避孕套保护。数据不足以确定报告的传播是发生在cART治疗6个月之前还是之后。根据传播是发生在cART治疗6个月之前还是之后,我们估计每次行为的HIV传播风险上限为8.7或13:100000。无论索引伴侣是否病毒抑制,这些估计均适用。估计风险上限<1:100000需要在收集的数据量是现有数据量12倍以上时未观察到HIV传播。
现有数据不支持cART治疗下HIV传播零风险。在综合护理中,与接受cART治疗超过6个月的HIV感染者进行无保护性行为时每次行为的HIV传播风险(无论是否病毒抑制)<13:100000。由于大多数研究中HIV血清学不一致夫妇中避孕套使用率高,估计风险上限降低10倍可能不可行。